Scarica l'app Stockscreener
8.70
27.75%
1.89
Dopo l'orario di chiusura:
8.50
-0.20
-2.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NXTC Giù?
Forum
Previsione
Precedente Chiudi:
$6.81
Aprire:
$6.79
Volume 24 ore:
352.89K
Relative Volume:
3.37
Capitalizzazione di mercato:
$23.28M
Reddito:
-
Utile/perdita netta:
$-58.52M
Rapporto P/E:
-4.1627
EPS:
-2.09
Flusso di cassa netto:
$-45.03M
1 W Prestazione:
+33.23%
1M Prestazione:
+53.57%
6M Prestazione:
+2,499%
1 anno Prestazione:
+491.84%
Intervallo 1D:
$6.71
$8.70
Intervallo di 1 settimana:
$6.23
$8.70
Portata 52W:
$0.224
$8.70
Nextcure Inc Stock (NXTC) Company Profile
Nome
Nextcure Inc
Settore
Industria
Telefono
240-399-4900
Indirizzo
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Confronta NXTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
8.70 | 17.98M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-04 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-03-05 | Aggiornamento | Truist | Hold → Buy |
| 2021-01-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-07-16 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-07-13 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-07-13 | Downgrade | SunTrust | Buy → Hold |
| 2020-06-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-05-26 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-03-24 | Iniziato | The Benchmark Company | Buy |
| 2020-03-02 | Iniziato | ROTH Capital | Buy |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-12-05 | Iniziato | Needham | Buy |
| 2019-11-26 | Iniziato | BTIG Research | Buy |
| 2019-07-09 | Iniziato | BofA/Merrill | Buy |
| 2019-06-03 | Iniziato | Morgan Stanley | Overweight |
| 2019-06-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Nextcure Inc Borsa (NXTC) Ultime notizie
Quantitative breakdown of NextCure Inc. recent moveGap Up & Low Risk High Win Rate Stock Picks - newser.com
Will NextCure Inc. stock outperform growth indexes2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Is NextCure Inc. stock a buy for dividend growthTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
NextCure, Inc. and Simcere Zaiming Announce Dosing of First U.S. Patient in Phase 1 Trial of SIM0505 for Advanced Solid Tumors - Quiver Quantitative
NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States - The Manila Times
NextCure And Simcere Zaiming Announce Expansion Of Ongoing Phase 1 Trial Of SIM0505 Into The US - TradingView
First U.S. patient dosed for SIM0505 — NextCure & Simcere expand Phase 1; PoC targeted 1H 2026 - Stock Titan
How NextCure Inc. stock reacts to inflationary pressuresDollar Strength & Weekly Stock Performance Updates - newser.com
Predicting NextCure Inc. trend using moving averagesJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
How institutional ownership impacts NextCure Inc. stockJuly 2025 Big Picture & AI Optimized Trade Strategies - newser.com
Has NextCure Inc. found a price floorPortfolio Profit Report & Expert Verified Movement Alerts - newser.com
Will breakout in NextCure Inc. lead to full recoveryPortfolio Risk Report & Fast Gain Swing Alerts - newser.com
Why analysts remain bullish on NextCure Inc. stockOil Prices & Technical Confirmation Trade Alerts - newser.com
Volatility clustering patterns for NextCure Inc.Trade Ideas & Free Safe Entry Trade Signal Reports - newser.com
Can momentum traders help lift NextCure Inc.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com
What drives NextCure Inc stock priceHigh Frequency Trading Trends & High Profit Trading Signals - earlytimes.in
How to use Fibonacci retracement on NextCure Inc.Trade Risk Assessment & Low Volatility Stock Suggestions - newser.com
Using Ichimoku Cloud for NextCure Inc. technicalsJuly 2025 Update & Free Real-Time Market Sentiment Alerts - newser.com
NextCure (NASDAQ:NXTC) Shares Up 1.2% – What’s Next? - Defense World
Using portfolio simulators with NextCure Inc. included2025 Trade Ideas & Verified Short-Term Plans - newser.com
What high frequency data says about NextCure Inc.Weekly Trend Report & Technical Entry and Exit Tips - newser.com
Why NextCure Inc. is moving todayTrade Entry Report & Reliable Price Breakout Signals - newser.com
What machine learning models say about NextCure Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Is it too late to sell NextCure Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Real time social sentiment graph for NextCure Inc.Weekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Will a bounce in NextCure Inc. offer an exitJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
Is NextCure Inc a good long term investmentCovered Call Writing & Collaborate and Win Together - earlytimes.in
NextCure Inc. stock chart pattern explainedTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com
Nextcure Inc Azioni (NXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):